Announced today that it has been granted USA Patent No.

‘In addition, it further secures Amedica’s upcoming competitive position in the reconstructive implant segment, which is one of the largest and rapidly-growing segments in the market.’.. Amedica Corporation receives patent for knee implant prosthesis with monoblock ceramic tibial component Amedica Corporation, a spinal and orthopaedic implant and instrument company centered on unique silicon nitride ceramic technologies, announced today that it has been granted USA Patent No. 7,776,085 B2, covering a better knee implant prosthesis that has a monoblock ceramic tibial element for articulation with natural or prosthetic femoral surfaces.Colleagues and Grollman proved AA to be the causative agent of endemic nephropathy in the Balkans, solving a 50-year-aged medical mystery that pointed to the ingestion of Aristolochia clematitis, or birthwort, contained in wheat. The study results were reported in Kidney International recently. Using their previous work in the Balkans as helpful information, Dr. Grollman and co-workers looked toward other areas where Aristolochia may be consumed and in which there was a high incidence of kidney disease and UUC. Taiwan seemed to demonstrate specifically that connection. We believe our latest analysis highlights the importance of a long-overlooked disease that impacts a lot of people in Taiwan, and, by extension, in China and other countries worldwide, where Aristolochia herbal remedies have been used for medicinal purposes traditionally, says Dr.